Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rimda Wanchoo

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Clinical Journal of the American Society of Nephrology : CJASN|September 24, 2024
Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies-Perspectives from the American Society of Onco-Nephrology (ASON)Abhijat Kitchlu, Verônica T Costa E Silva, Shuchi Anand, et al.
Journal for Immunotherapy of Cancer|September 22, 2022
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKIShruti Gupta, Clara Garcia-Carro, Jason M Prosek, et al.
Nature Reviews. Nephrology|December 9, 2025
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroupAmanda DeMauro Renaghan, Marlies Ostermann, Claudio Ronco, et al.
Kidney International|December 28, 2020
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplantNaoka Murakami, Patrick Mulvaney, Melissa Danesh, et al.
Journal for Immunotherapy of Cancer|October 9, 2021
Acute kidney injury in patients treated with immune checkpoint inhibitorsShruti Gupta, Samuel A P Short, Meghan E Sise, et al.
Kidney360|March 30, 2023
COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International RegistryMeryl Waldman, Ninet Sinaii, Edgar V Lerma, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Clinical Journal of the American Society of Nephrology : CJASN|September 24, 2024
Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies-Perspectives from the American Society of Onco-Nephrology (ASON)Abhijat Kitchlu, Verônica T Costa E Silva, Shuchi Anand, et al.
Journal for Immunotherapy of Cancer|September 22, 2022
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKIShruti Gupta, Clara Garcia-Carro, Jason M Prosek, et al.
Nature Reviews. Nephrology|December 9, 2025
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroupAmanda DeMauro Renaghan, Marlies Ostermann, Claudio Ronco, et al.
Kidney International|December 28, 2020
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplantNaoka Murakami, Patrick Mulvaney, Melissa Danesh, et al.
Journal for Immunotherapy of Cancer|October 9, 2021
Acute kidney injury in patients treated with immune checkpoint inhibitorsShruti Gupta, Samuel A P Short, Meghan E Sise, et al.
Kidney360|March 30, 2023
COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International RegistryMeryl Waldman, Ninet Sinaii, Edgar V Lerma, et al.
Pageof 7